- Home
- ACHV vs NCTY Comparison
ACHV vs NCTY Comparison
Compare ACHV & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- NCTY
- Stock Information
- Founded
- ACHV N/A
- NCTY 1999
- Country
- ACHV United States
- NCTY China
- Employees
- ACHV N/A
- NCTY N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NCTY Business Services
- Sector
- ACHV Health Care
- NCTY Consumer Discretionary
- Exchange
- ACHV Nasdaq
- NCTY Nasdaq
- Market Cap
- ACHV 131.2M
- NCTY 121.2M
- IPO Year
- ACHV N/A
- NCTY 2004
- Fundamental
- Price
- ACHV $2.55
- NCTY $7.54
- Analyst Decision
- ACHV Strong Buy
- NCTY
- Analyst Count
- ACHV 3
- NCTY 0
- Target Price
- ACHV $14.33
- NCTY N/A
- AVG Volume (30 Days)
- ACHV 652.7K
- NCTY 33.6K
- Earning Date
- ACHV 08-07-2025
- NCTY 01-01-0001
- Dividend Yield
- ACHV N/A
- NCTY N/A
- EPS Growth
- ACHV N/A
- NCTY N/A
- EPS
- ACHV N/A
- NCTY N/A
- Revenue
- ACHV N/A
- NCTY $15,305,175.00
- Revenue This Year
- ACHV N/A
- NCTY N/A
- Revenue Next Year
- ACHV N/A
- NCTY N/A
- P/E Ratio
- ACHV N/A
- NCTY N/A
- Revenue Growth
- ACHV N/A
- NCTY N/A
- 52 Week Low
- ACHV $1.84
- NCTY $6.28
- 52 Week High
- ACHV $5.31
- NCTY $20.59
- Technical
- Relative Strength Index (RSI)
- ACHV 46.32
- NCTY 36.34
- Support Level
- ACHV $2.37
- NCTY $7.41
- Resistance Level
- ACHV $2.56
- NCTY $8.42
- Average True Range (ATR)
- ACHV 0.12
- NCTY 0.62
- MACD
- ACHV 0.01
- NCTY -0.12
- Stochastic Oscillator
- ACHV 47.37
- NCTY 6.70
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.